Osaic Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,418
| Closed | -$341K | – | 7585 |
|
|
2023
Q3 | $341K | Sell |
18,418
-23,278
| -56% | -$263K | ﹤0.01% | 3574 |
|
|
2023
Q2 | $461K | Sell |
41,696
-790
| -2% | -$11K | ﹤0.01% | 3212 |
|
|
2023
Q1 | $571K | Sell |
42,486
-3,413
| -7% | -$59K | ﹤0.01% | 2976 |
|
|
2022
Q4 | $568K | Buy |
45,899
+32,968
| +255% | +$467K | ﹤0.01% | 2907 |
|
|
2022
Q3 | $180K | Sell |
12,931
-362
| -3% | -$5.83K | ﹤0.01% | 3854 |
|
|
2022
Q2 | $184K | Sell |
13,293
-409
| -3% | -$6.55K | ﹤0.01% | 3879 |
|
|
2022
Q1 | $222K | Sell |
13,702
-1,960
| -13% | -$30.7K | ﹤0.01% | 3949 |
|
|
2021
Q4 | $255K | Sell |
15,662
-239
| -2% | -$4.03K | ﹤0.01% | 3729 |
|
|
2021
Q3 | $236K | Sell |
15,901
-377
| -2% | -$6.03K | ﹤0.01% | 3753 |
|
|
2021
Q2 | $324K | Sell |
16,278
-28,050
| -63% | -$556K | ﹤0.01% | 3440 |
|
|
2021
Q1 | $1.02M | Sell |
44,328
-10,077
| -19% | -$281K | ﹤0.01% | 2210 |
|
|
2020
Q4 | $1.34M | Sell |
54,405
-19,993
| -27% | -$663K | ﹤0.01% | 1778 |
|
|
2020
Q3 | $3.09M | Sell |
74,398
-1,000
| -1% | -$45.9K | 0.01% | 1037 |
|
|
2020
Q2 | $3.61M | Buy |
75,398
+263
| +0.4% | +$20.3K | 0.01% | 873 |
|
|
2020
Q1 | $4.73M | Buy |
+75,135
| New | +$6.75M | 0.02% | 633 |
|
Osaic Holdings's ICPT Position: Q4 2023 in Review
Osaic Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 18,418 shares — an estimated $341K sold.
Osaic Holdings first reported a position in ICPT in Q1 2020 and held it in 15 quarters. The position peaked at $4.73M in Q1 2020. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Osaic Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Osaic Holdings sold 18,418 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $341K.
- Osaic Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2020 and held it in 15 quarters.
- Osaic Holdings's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.